PTPRC and leukemia: Leukemia development ability was quantified using the proportion of NSG mice with over 1% hCD7+CD45+ cells at a given time point (5 weeks for T-ALL1, 7 weeks for T-ALL3 and 20 weeks for T-ALL5).